Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | PF-06940434 |
Synonyms | |
Therapy Description |
PF-06940434 is an integrin alpha v beta 8 antagonist that prevents the activation of TGFB1, leading to an anti-tumor response (Mar 2020). |